Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BayMedica logo — BayMedica leverages synthetic biology and chemistry to devel...

BayMedica

BayMedica leverages synthetic biology and chemistry to develop rare cannabinoids. A division of InMed Pharmaceuticals.

Founded 2016 United States United States 8 employees Biotechnology, Health Care

General Information

Company Name BayMedica
Founded Year 2016
Location United States United States
Employees 8
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with BayMedica. To contact BayMedica, visit baymedica.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BayMedica compare?

A PDF of BayMedica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BayMedica soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BayMedica

BayMedica is a revenue-stage biotechnology company and a division of InMed Pharmaceuticals (Nasdaq: INM). Leveraging synthetic biology and pharmaceutical chemistry, the company focuses on developing an efficient, scalable, and proprietary platform for producing high quality, rare cannabinoids for consumer applications and cannabinoid-derived new chemical entities for pharmaceutical applications. Founded in 2016, BayMedica is positioned at the intersection of Biotechnology and Health Care industries with its headquarters in the United States. With a background in synthetic biology and chemistry, BayMedica has the potential to bring a disruptive approach to rare cannabinoid production. The company's alliance with InMed Pharmaceuticals provides it with a strong foundation and access to resources that could drive its growth. The absence of information regarding last investment and last investment investors suggests an opportunity for potential investors to further explore the possibilities of collaborations or funding. As the market for rare cannabinoids grows, BayMedica presents an intriguing prospect for investors interested in the biotechnology and healthcare sectors.

Business keywords: Synthetic Biology, Pharmaceuticals, Cannabinoids, Health & Wellness, Animal Health, Cosmetics, Nutraceuticals, Chemistry, Biosynthesis, Revenue-stage Company, Rare Cannabinoids, New Chemical Entities, Consumer Applications, Scalable Platform

No funding data available for BayMedica yet.

BayMedica Alternatives & Competitors

View All Alternatives
BayMedica vs
InMed Pharmaceuticals
InMed Pharmaceuticals Canada

Global leader in the manufacturing and development of rare cannabinoids. Our subsidiary is Baymedica...

Post-IPO Equity
18 employees
Biotechnology, Health Care
BayMedica vs
AMPLY Discovery
AMPLY Discovery United Kingdom

Turning the Dark Genome into Novel Medicines.

7 employees
AI, Biotechnology
BayMedica vs
Synlogic
Synlogic United States

Designed for Life

IPO
20 employees
Biotechnology, Health Care
View all alternatives

FAQ About BayMedica

BayMedica leverages synthetic biology and chemistry to develop rare cannabinoids. A division of InMed Pharmaceuticals.
BayMedica was founded in 2016.
BayMedica is headquartered in United States.
BayMedica operates in Biotechnology and Health Care. Its work centres on Synthetic Biology, Pharmaceuticals, Cannabinoids and Health & Wellness.
BayMedica has approximately 8 employees.
Top alternatives and competitors to BayMedica include InMed Pharmaceuticals, AMPLY Discovery, Synlogic, Pividl Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BayMedica and InMed Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BayMedica, https://bouncewatch.com/company/baymedica, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout